Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $394.1400 (3.03%) ($382.0600 - $401.2099) on Wed. Mar. 29, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.02% (three month average) | RSI | 51 | Latest Price | $394.1400(3.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.3% a day on average for past five trading days. | Weekly Trend | REGN declines -1.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(49%) XBI(44%) IVW(42%) QQQ(42%) | Factors Impacting REGN price | REGN will decline at least -1.01% in a week (0% probabilities). VIXM(-8%) UUP(-8%) TLT(-6%) IPO(-2%) TIP(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.01% (StdDev 2.02%) | Hourly BBV | 0 () | Intraday Trend | 3.1% | | | |
|
5 Day Moving Average | $379.68(3.81%) | 10 Day Moving Average | $379.39(3.89%) | 20 Day Moving Average | $381.96(3.19%) | To recent high | -0.9% | To recent low | 15.7% | Market Cap | $41.79b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |